Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
Anticancer Research|August 1, 2018
OPG, OPN, EGF and VEGF Levels at Individual Breslow Score Stages in Malignant MelanomaInka Treskova, Ondrej Topolcan, Jindra Windrichova, et al.
Anticancer Research|June 13, 2014
Predictive role of CEA and CYFRA 21-1 in patients with advanced-stage NSCLC treated with erlotinibOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Clinics and Practice|November 21, 2023
Predicting Chronic Hyperplastic Candidiasis Retro-Angular Mucosa Using Machine LearningOmid Moztarzadeh, Jan Liska, Veronika Liskova, et al.
Cytokines, Cellular & Molecular Therapy|July 10, 2003
Inflammation in the wall of abdominal aortic aneurysm and its role in the symptomatology of aneurysmVladislav Treska, Jitka Kocova, Ludmila Boudova, et al.
Anticancer Research|March 19, 2017
MIC1/GDF15 as a Bone Metastatic Disease BiomarkerJindra Windrichova, Radka Fuchsova, Radek Kucera, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 7, 2015
Reference values of IGF1, IGFBP3 and IGF1/IGFBP3 ratio in adult population in the Czech RepublicRadek Kucera, Ondrej Topolcan, Ladislav Pecen, et al.
Anticancer Research|March 16, 2016
The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line ChemotherapyMartin Svaton, Ondrej Fiala, Milos Pesek, et al.
Hepato-Gastroenterology|November 21, 2007
Recurrence of colorectal liver metastases after surgical treatment: multifactorial studyVaclav Liska, Vladislav Treska, Lubos Holubec, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 23, 2015
Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutationOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Pageof 13